Advances in the early detection, diagnosis, and staging of pancreatic cancer

被引:51
作者
Riker, A [1 ]
Libutti, SK [1 ]
Bartlett, DL [1 ]
机构
[1] NCI, NIH, Surg Branch, Bethesda, MD 20892 USA
来源
SURGICAL ONCOLOGY-OXFORD | 1997年 / 6卷 / 03期
关键词
pancreatic cancer; magnetic resonance imaging (MRI); positron emission tomography (PET); laparoscopy; endoscopic ultrasound (EUS); review;
D O I
10.1016/S0960-7404(97)00025-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic cancer is an aggressive disease with a dismal prognosis, It has long been regarded as one of the most difficult cancers to accurately diagnose and stage preoperatively, The purpose of this review is to provide an update of the state-of-the-art for early detection, diagnosis, and staging of pancreatic cancer, These methods include spiral CT scans, magnetic resonance imaging, positron emission tomography (PET) imaging, laparoscopy, endoscopic ultrasound, CA 19-9 serology, fine needle aspiration cytology, ERCP brush cytology, and screening for p53 and ras oncogenes, These advanced techniques should help us to detect pancreatic cancers in high-risk populations at a curative stage and to decrease pancreatico-duodenectomies for benign disease which could otherwise be treated with less morbid procedures, In addition, these tests will help reliably diagnose pancreatic cancer preoperatively, (C) 1998 Elsevier Science Ltd.
引用
收藏
页码:157 / 169
页数:13
相关论文
共 79 条
[1]   IDENTIFICATION AND CHARACTERIZATION OF MUSCARINIC RECEPTORS IN CULTURED HUMAN PANCREATIC-CARCINOMA CELLS [J].
ACKERMAN, MS ;
ROESKE, WR ;
HECK, RJ ;
KORC, M .
PANCREAS, 1989, 4 (03) :363-370
[2]   MOST HUMAN CARCINOMAS OF THE EXOCRINE PANCREAS CONTAIN MUTANT C-K-RAS GENES [J].
ALMOGUERA, C ;
SHIBATA, D ;
FORRESTER, K ;
MARTIN, J ;
ARNHEIM, N ;
PERUCHO, M .
CELL, 1988, 53 (04) :549-554
[3]  
Apple SK, 1996, AM J CLIN PATHOL, V105, P321
[4]   CA 19.9, CA 242 and CEA in the diagnosis and follow-up of pancreatic cancer [J].
Banfi, G ;
Bravi, S ;
Ardemagni, A ;
Zerbi, A .
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1996, 11 (02) :77-81
[5]   F-18 FLUORODEOXYGLUCOSE PET IN-VIVO EVALUATION OF PANCREATIC GLUCOSE-METABOLISM FOR DETECTION OF PANCREATIC-CANCER [J].
BARES, R ;
KLEVER, P ;
HAUPTMANN, S ;
HELLWIG, D ;
FASS, J ;
CREMERIUS, U ;
SCHUMPELICK, V ;
MITTERMAYER, C ;
BULL, U .
RADIOLOGY, 1994, 192 (01) :79-86
[6]  
BARES R, 1993, J NUCL MED, V34, pP98
[7]   ABNORMALITIES OF THE P53 TUMOR SUPPRESSOR GENE IN HUMAN PANCREATIC-CANCER [J].
BARTON, CM ;
STADDON, SL ;
HUGHES, CM ;
HALL, PA ;
OSULLIVAN, C ;
KLOPPEL, G ;
THEIS, B ;
RUSSELL, RCG ;
NEOPTOLEMOS, J ;
WILLIAMSON, RCN ;
LANE, DP ;
LEMOINE, NR .
BRITISH JOURNAL OF CANCER, 1991, 64 (06) :1076-1082
[8]   A CLINICAL-EVALUATION OF MONOCLONAL (CA19-9, CA50, CA12-5) AND POLYCLONAL (CEA, TPA) ANTIBODY-DEFINED ANTIGENS FOR THE DIAGNOSIS OF PANCREATIC-CANCER [J].
BENINI, L ;
CAVALLINI, G ;
ZORDAN, D ;
RIZZOTTI, P ;
RIGO, L ;
BROCCO, G ;
PEROBELLI, L ;
ZANCHETTA, M ;
PEDERZOLI, P ;
SCURO, LA .
PANCREAS, 1988, 3 (01) :61-66
[9]   COMPARATIVE-ANALYSIS OF MUTATIONS IN THE P53 AND K-RAS GENES IN PANCREATIC-CANCER [J].
BERROZPE, G ;
SCHAEFFER, J ;
PEINADO, MA ;
REAL, FX ;
PERUCHO, M .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (02) :185-191
[10]   IDENTIFICATION OF K-RAS MUTATIONS IN PANCREATIC-JUICE IN THE EARLY DIAGNOSIS OF PANCREATIC-CANCER [J].
BERTHELEMY, P ;
BOUISSON, M ;
ESCOURROU, J ;
VAYSSE, N ;
RUMEAU, JL ;
PRADAYROL, L .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (03) :188-191